Use of Bone Marrow Stromal Cell-derived Fate-committed Glial Precursors for Remyelination Therapy
Year: 2023
Type: article
Abstract: Donor nerve-derived Schwann cells transplanted to the severed nerve/tract in the PNS/CNS improves prospects of post-traumatic recovery in rat models. Clinical translation however requires sufficient quantities of immuno-compatible and fate-committed glial precursors. Following pilot studies with rat cells, we enriched the neuroprogenitor subpopulation among human bone marrow (hBM) stromal cells in culture and then with selected glia-inducing supplements, yielded either Schwann cell-like cells (SCLCs) or oligodendrocyte precursors (OPs).
Source: IBRO Neuroscience Reports
Institution: University of Hong Kong
Language: English
Subfield: Developmental Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,500
Awards: G2835072274, G6010422611
OpenAlex ID: W4388364247
